{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:55:38Z","timestamp":1792713338039,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T00:00:00Z","timestamp":1456099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UL2010-4801"],"award-info":[{"award-number":["UL2010-4801"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UL2014-6696"],"award-info":[{"award-number":["UL2014-6696"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UL2014-6696"],"award-info":[{"award-number":["UL2014-6696"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00262-016-1805-x","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T06:35:41Z","timestamp":1456122941000},"page":"393-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency"],"prefix":"10.1007","volume":"65","author":[{"given":"Simone","family":"Punt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie A. C.","family":"Dronkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marij J. P.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske","family":"Goedemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senada","family":"Koljenovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bloemena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J. F.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arko","family":"Gorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd H.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J. Baatenburg","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina S.","family":"Jordanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000381717","volume":"89","author":"F Pezzuto","year":"2015","unstructured":"Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C et al (2015) Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology\u00a089:125\u2013136. doi: 10.1159\/000381717","journal-title":"Oncology"},{"key":"1805_CR2","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/ijc.26195","volume":"130","author":"HS Monsjou van","year":"2012","unstructured":"van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130:1806\u20131812. doi: 10.1002\/ijc.26195","journal-title":"Int J Cancer"},{"key":"1805_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. doi: 10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"1805_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bjoms.2010.06.023","volume":"49","author":"R Shaw","year":"2011","unstructured":"Shaw R, Robinson M (2011) The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg 49:423\u2013429. doi: 10.1016\/j.bjoms.2010.06.023","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1805_CR5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.27821","volume":"132","author":"MM Rietbergen","year":"2013","unstructured":"Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT et al (2013) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565\u20131571. doi: 10.1002\/ijc.27821","journal-title":"Int J Cancer"},{"key":"1805_CR6","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294\u20134301. doi: 10.1200\/JCO.2011.36.4596","journal-title":"J Clin Oncol"},{"key":"1805_CR7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/PPO.0000000000000115","volume":"21","author":"AP Stein","year":"2015","unstructured":"Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambert PF et al (2015) Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review. Cancer J 21:138\u2013146. doi: 10.1097\/PPO.0000000000000115","journal-title":"Cancer J"},{"key":"1805_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335. doi: 10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"1805_CR9","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","volume":"24","author":"L Licitra","year":"2006","unstructured":"Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630\u20135636. doi: 10.1200\/JCO.2005.04.6136","journal-title":"J Clin Oncol"},{"key":"1805_CR10","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/annonc\/mdt319","volume":"24","author":"MM Rietbergen","year":"2013","unstructured":"Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA et al (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 24:2740\u20132745. doi: 10.1093\/annonc\/mdt319","journal-title":"Ann Oncol"},{"key":"1805_CR11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archoto.2010.211","volume":"136","author":"D Wansom","year":"2010","unstructured":"Wansom D, Light E, Worden F, Prince M, Urba S, Chepeha DB et al (2010) Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 136:1267\u20131273. doi: 10.1001\/archoto.2010.211","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1805_CR12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejca.2014.12.018","volume":"51","author":"I Tinhofer","year":"2015","unstructured":"Tinhofer I, Johrens K, Keilholz U, Kaufmann A, Lehmann A, Weichert W et al (2015) Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer 51:514\u2013521. doi: 10.1016\/j.ejca.2014.12.018","journal-title":"Eur J Cancer"},{"key":"1805_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319. doi: 10.1002\/(SICI)1096-9896(199909)189:1<12:AID-PATH431>3.0.CO;2-F","journal-title":"J Pathol"},{"key":"1805_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GY Ho","year":"1998","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423\u2013428. doi: 10.1056\/NEJM199802123380703","journal-title":"N Engl J Med"},{"key":"1805_CR15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539\u2013545. doi: 10.1016\/S0140-6736(00)04046-0","journal-title":"Lancet"},{"key":"1805_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hed.23736","volume":"37","author":"SP Wallis","year":"2015","unstructured":"Wallis SP, Stafford ND, Greenman J (2015) Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Head Neck 37:449\u2013459. doi: 10.1002\/hed.23736","journal-title":"Head Neck"},{"key":"1805_CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semcancer.2012.03.004","volume":"22","author":"TL Whiteside","year":"2012","unstructured":"Whiteside TL (2012) What are regulatory T cells (Treg) regulating in cancer and why? Semin Cancer Biol 22:327\u2013334. doi: 10.1016\/j.semcancer.2012.03.004","journal-title":"Semin Cancer Biol"},{"key":"1805_CR18","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","volume":"25","author":"Q Gao","year":"2007","unstructured":"Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586\u20132593. doi: 10.1200\/JCO.2006.09.4565","journal-title":"J Clin Oncol"},{"key":"1805_CR19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942\u2013949. doi: 10.1038\/nm1093","journal-title":"Nat Med"},{"key":"1805_CR20","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ejca.2008.05.017","volume":"44","author":"G Perrone","year":"2008","unstructured":"Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P et al (2008) Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer 44:1875\u20131882. doi: 10.1016\/j.ejca.2008.05.017","journal-title":"Eur J Cancer"},{"key":"1805_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","volume":"12","author":"C Badoual","year":"2006","unstructured":"Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay NH et al (2006) Prognostic value of tumor-infiltrating CD4\u00a0+\u00a0T-cell subpopulations in head and neck cancers. Clin Cancer Res 12:465\u2013472. doi: 10.1158\/1078-0432.CCR-05-1886","journal-title":"Clin Cancer Res"},{"key":"1805_CR22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","volume":"77","author":"LL Cunha","year":"2012","unstructured":"Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S et al (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77:918\u2013925. doi: 10.1111\/j.1365-2265.2012.04482.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1805_CR23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","volume":"27","author":"P Salama","year":"2009","unstructured":"Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D et al (2009) Tumor-infiltrating FOXP3\u00a0+\u00a0T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186\u2013192. doi: 10.1200\/JCO.2008.18.7229","journal-title":"J Clin Oncol"},{"key":"1805_CR24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00262-011-1046-y","volume":"60","author":"S Ladoire","year":"2011","unstructured":"Ladoire S, Martin F, Ghiringhelli F (2011) Prognostic role of FOXP3\u00a0+\u00a0regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60:909\u2013918. doi: 10.1007\/s00262-011-1046-y","journal-title":"Cancer Immunol Immunother"},{"key":"1805_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajpath.2012.08.041","volume":"182","author":"J Ye","year":"2013","unstructured":"Ye J, Livergood RS, Peng G (2013) The role and regulation of human Th17 cells in tumor immunity. Am J Pathol 182:10\u201320. doi: 10.1016\/j.ajpath.2012.08.041","journal-title":"Am J Pathol"},{"key":"1805_CR26","doi-asserted-by":"crossref","first-page":"e984539","DOI":"10.4161\/2162402X.2014.984539","volume":"4","author":"S Punt","year":"2015","unstructured":"Punt S, Fleuren GJ, Kritikou E, Lubberts E, Trimbos JB, Jordanova ES et al (2015) Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer. Oncoimmunology 4:e984539. doi: 10.4161\/2162402X.2014.984539","journal-title":"Oncoimmunology"},{"key":"1805_CR27","doi-asserted-by":"crossref","first-page":"e984547","DOI":"10.4161\/2162402X.2014.984547","volume":"4","author":"S Punt","year":"2015","unstructured":"Punt S, Langenhoff JM, Putter H, Fleuren GJ, Gorter A, Jordanova ES (2015) The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review. Oncoimmunology 4:e984547. doi: 10.4161\/2162402X.2014.984547","journal-title":"Oncoimmunology"},{"key":"1805_CR28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1128\/JCM.03195-13","volume":"52","author":"AT Hesselink","year":"2014","unstructured":"Hesselink AT, Berkhof J, van der Salm ML, van Splunter AP, Geelen TH, van Kemenade FJ et al (2014) Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region. J Clin Microbiol 52:890\u2013896. doi: 10.1128\/JCM.03195-13","journal-title":"J Clin Microbiol"},{"key":"1805_CR29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00262-015-1678-4","volume":"64","author":"S Punt","year":"2015","unstructured":"Punt S, van Vliet ME, Spaans VM, de Kroon CD, Fleuren GJ, Gorter A et al (2015) FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma. Cancer Immunol Immunother 64:745\u2013753. doi: 10.1007\/s00262-015-1678-4","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1805_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24\u201335. doi: 10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"issue":"11","key":"1805_CR31","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/bjc.2015.139","volume":"112","author":"MM Rietbergen","year":"2015","unstructured":"Rietbergen MM, Witte BI, Velazquez ER, Snijders PJ, Bloemena E, Speel EJ et al (2015) Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe. Br J Cancer 112(11):1733\u20131736. doi: 10.1038\/bjc.2015.139","journal-title":"Br J Cancer"},{"key":"1805_CR32","doi-asserted-by":"crossref","first-page":"e38711","DOI":"10.1371\/journal.pone.0038711","volume":"7","author":"A Nasman","year":"2012","unstructured":"Nasman A, Romanitan M, Nordfors C, Grun N, Johansson H, Hammarstedt L et al (2012) Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 7:e38711. doi: 10.1371\/journal.pone.0038711","journal-title":"PLoS One"},{"key":"1805_CR33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2009.02.015","volume":"74","author":"CS Kong","year":"2009","unstructured":"Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A et al (2009) The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 74:553\u2013561. doi: 10.1016\/j.ijrobp.2009.02.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1805_CR34","doi-asserted-by":"crossref","first-page":"e965570","DOI":"10.4161\/21624011.2014.965570","volume":"4","author":"S Partlova","year":"2015","unstructured":"Partlova S, Boucek J, Kloudova K, Lukesova E, Zabrodsky M, Grega M et al (2015) Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology 4:e965570. doi: 10.4161\/21624011.2014.965570","journal-title":"Oncoimmunology"},{"key":"1805_CR35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-014-1630-6","volume":"465","author":"R Krupar","year":"2014","unstructured":"Krupar R, Robold K, Gaag D, Spanier G, Kreutz M, Renner K et al (2014) Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch 465:299\u2013312. doi: 10.1007\/s00428-014-1630-6","journal-title":"Virchows Arch"},{"issue":"6","key":"1805_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/odi.12037","volume":"19","author":"AW Turksma","year":"2013","unstructured":"Turksma AW, Bontkes HJ, van den Heuvel H, de Gruijl TD, von Blomberg BM, Braakhuis BJ et al (2013) Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients. Oral Dis 19(6):577\u2013584. doi: 10.1111\/odi.12037","journal-title":"Oral Dis"},{"key":"1805_CR37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.2013.639","volume":"110","author":"MJ Ward","year":"2014","unstructured":"Ward MJ, Thirdborough SM, Mellows T, Riley C, Harris S, Suchak K et al (2014) Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer 110:489\u2013500. doi: 10.1038\/bjc.2013.639","journal-title":"Br J Cancer"},{"key":"1805_CR38","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.ejca.2013.03.019","volume":"49","author":"C Nordfors","year":"2013","unstructured":"Nordfors C, Grun N, Tertipis N, Ahrlund-Richter A, Haeggblom L, Sivars L et al (2013) CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 49:2522\u20132530. doi: 10.1016\/j.ejca.2013.03.019","journal-title":"Eur J Cancer"},{"key":"1805_CR39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/0008-5472.CAN-06-3388","volume":"67","author":"SJ Piersma","year":"2007","unstructured":"Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW et al (2007) High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 67:354\u2013361. doi: 10.1158\/0008-5472.CAN-06-3388","journal-title":"Cancer Res"},{"key":"1805_CR40","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/1078-0432.CCR-07-4554","volume":"14","author":"ES Jordanova","year":"2008","unstructured":"Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG et al (2008) Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8\u00a0+\/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14:2028\u20132035. doi: 10.1158\/1078-0432.CCR-07-4554","journal-title":"Clin Cancer Res"},{"key":"1805_CR41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-015-0350-0","volume":"14","author":"S Punt","year":"2015","unstructured":"Punt S, Houwing-Duistermaat JJ, Schulkens IA, Thijssen VL, Osse EM, de Kroon CD et al (2015) Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Mol Cancer 14:71. doi: 10.1186\/s12943-015-0350-0","journal-title":"Mol Cancer"},{"key":"1805_CR42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2014.00276","volume":"5","author":"SR Bailey","year":"2014","unstructured":"Bailey SR, Nelson MH, Himes RA, Li Z, Mehrotra S, Paulos CM (2014) Th17 cells in cancer: the ultimate identity crisis. Front Immunol 5:276. doi: 10.3389\/fimmu.2014.00276","journal-title":"Front Immunol"},{"key":"1805_CR43","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","volume":"35","author":"P Muranski","year":"2011","unstructured":"Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L et al (2011) Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35:972\u2013985. doi: 10.1016\/j.immuni.2011.09.019","journal-title":"Immunity"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1805-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-016-1805-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1805-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T17:17:21Z","timestamp":1567617441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-016-1805-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1805-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]}}}